Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Laura Brege currently holds 32,703 shares of ACADIA PHARMACEUTICALS INC (ACAD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Laura Brege has been a net seller of ACAD stock. They have purchased $125.0K and sold $17.3M worth of shares.
Laura Brege's most recent insider trade was on Sep 11, 2025, when they sold 17,000 shares at $15.00 per share.
Laura Brege serves as Executive at ACADIA PHARMACEUTICALS INC (ACAD). They have executed 137 insider transactions totaling $17.4M over their tenure at the company.
Laura Brege holds the position of Executive at ACADIA PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Laura Brege has shown a selling trading pattern, with $125.0K in total purchases and $17.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Laura Brege was on Sep 11, 2025, when they sold $1.2M worth of MIRM shares. This transaction involved 15,509 shares at $74.34 per share.
Laura Brege currently owns 32,703 shares of ACADIA PHARMACEUTICALS INC (ACAD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Laura Brege's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Laura Brege has 137 Form 4 filings on record as an insider at ACADIA PHARMACEUTICALS INC.
Set alerts for Laura Brege and 40,000+ other insiders.